Molecular cloning of a cell-surface glycoprotein that can potentially discriminate mesothelium from epithelium: Its identification as vascular cell adhesion molecule 1

British Journal of Cancer

Volumn 71, Issue 3, 1995, Pages 562-570

  Yamada, T ^a   Jiping, J ^a   Endo, R ^a   Gotoh, M ^a   Shimosato, Y ^b   Hirohashi, S ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

INCAM 110; Mesothelioma; Mesothelium; VCAM1

Indexed keywords

COMPLEMENTARY DNA; GLYCOPROTEIN; MONOCLONAL ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DNA SEQUENCE; EPITHELIUM; EPITHELIUM TUMOR; GENE ISOLATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAMMAL CELL; MESOTHELIOMA; MESOTHELIUM; MESOTHELIUM CELL; MOLECULAR CLONING; MOLECULAR RECOGNITION; PRIORITY JOURNAL;

ANIMAL; ANTIBODIES, MONOCLONAL; BASE SEQUENCE; BLOTTING, NORTHERN; CELL ADHESION MOLECULES; CELLS, CULTURED; CLONING, MOLECULAR; DNA; EPITHELIUM; HUMAN; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; MESOTHELIOMA; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEOPLASMS; PLEURAL NEOPLASMS; POLYMERASE CHAIN REACTION; PRECIPITIN TESTS; RNA-DIRECTED DNA POLYMERASE; SUPPORT, NON-U.S. GOV'T; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0028957556     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1995.110     Document Type: Article

References (44)

1. ADEN DP, FOGEL A, PLOTKJN S, DAMJANOV I AND KNOWLES BB. (1979). Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature, 282, 615-616.
2. BRISCOE DM, COTRAN RS AND POBER JS. (1992). Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo. Correlation with CD3+ T cell infiltration. J, Immunol., 149, 2954-2960.
3. BUBENIK J, BARESOVA M, VIKLICKY V, JAKOUBKOVA J, SAINEROVA H AND DONNER J. (1973). Established cell fine of urinary bladder carcinoma (T24) containing tumor-specific antigen. Int J Cancer, 11, 765-773.
4. CANNISTRA SA KANSAS GS, NILOFF J, DEFRANZO B, KIM Y AND OTTENSMEIER C. (1993). Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H, Cancer Res., 53, 3830-3838.
5. CARNEY DN, GAZDAR AF, BEPLER G, GUCCION JG, MARANGOS PJ, MOODY TW, ZWEIG MH AND MINNA JD. (1985). Establishment AND identification of small cell lung cancer cell fines having classic AND variant features. Cancer Res., 45, 2913-2923.
6. CHANG K, PAI LH, PASS H, POGREBNIAK HW, TSAO MS, PASTAN I, and WILLINGHAM MC. (1992). Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma. Am. J, Surg. Pathol., 16, 259-268.
7. CHERNOW B AND SAHN SA. (1977). Carcinomatous involvement of pleura. An analysis of 96 patients. Am. J, Med., 63, 695-702.
8. CRAIGHEAD JE AND MOSSMAN BT. (1982). The pathogenesis of asbestos related disease. N, Engl. J, Med., 306, 1446-1455.
9. CYBULSKY MI, FRIES JWU, WILLIAMS AJ, SULTAN P, DAVIS VM, GIMBORNE Jr MA AND COLLINS T. (1991a). Alternative splicing of human VCAM-1 in activated vascular endothelium. Am. J, Pathol., 138, 815-820.
10. CYBULSKY MI, FRIES JWU, WILLIAMS AJ, SULTAN P, EDDY R, BYERS M, SHOWS T, GIMBORNE Jr MA AND COLLINS T (1991b). Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VC AMI gene. Proc. Natl Acad. Sci. USA, 88, 7859-7863.
11. DONNA A, BETTA PG AND JONES JSP. (1988). Verification of the histologic diagnosis of malignant mesothelioma in relation to the binding of an antimesothelial cell antibody. Cancer, 63, 1331-1336.
12. ELICES MJ, OSBORN L, TAKADA Y, CROUSE C, LUHOWSKYJ S, HEMLER ME AND LOBB RR. (1990). VCAM-1 on activated endothelium interacts with the leukocyte integrin in VLA-4 at a site distinct from the VLA-4 fibronectin binding site. Cell, 60, 577-584.
13. FREEDMAN AS, MUNRO JM, RICE GE, BEVILACQUA MP, MORIMOTO C, MACINTYRE BW, RHYNHART K, POBER JS AND NADLER LM. (1990). Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INC AM-110. Science, 249, 1030-1033.
14. GIARD DJ, AARONSON SA, TODARO GJ ARNSTEIN P, KERSEY JH, DOSIK H AND PARKS WP. (1973). In vitro cultivation of human tumors: establishment of cell fines derived from a series of solid tumors. J, Natl Cancer Inst., 51, 1417-1423.
15. GLUZMAN Y. (1981). SV40-transformed simian cells support the replication of early SV40 mutants. Cell, 23, 175-182.
16. HAYFLICK L AND MOORHEAD PS. (1961). The serial cultivation of human diploid cell strains. Exp. Cell Res., 25, 585-621.
17. HESSION C, TIZARD R, VASSALLO C, SCHIFFER SB, GOFF D, MOY P, CHI-ROSSO G, LUHOWSKYJ S, LOBB RR AND OSBORN L (1991). Cloning of an alternate form of vascular cell adhesion molecule-1 (VCAM1). J, Biol. Chem., 266, 6682-6685.
18. HIRANO T, HIROHASHI S, KUNII T, NOGUCHI M, SHIMOSATO Y AND HAYATA Y. (1989). Quantitative distribution of cluster 1 small cell lung cancer antigen in cancerous AND non-cancerous tissues, cultured cells AND sera. Jpn J, Cancer Res., 80, 348-355.
19. HIRT B. (1967). Selective extraction of polyoma DNA from infected mouse cell culture. J, Mol. Biol., 26, 365-369.
20. HSU SM, RAINE L AND FANGER H. (1981). Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC AND unlabeled (PAP) procedures. J, Histochem. Cytochem., 29, 577-580.
21. HSU SM, HSU PL, ZHAO X, KAO-SHAN CS AND WHANG-PENG J, Establishment of human mesothelioma cell fine (MS-1, -2) and production of a monoclonal antibody (Anti-MS) with diagnostic AND therapeutic potential. Cancer Res., 48, 5228-5236.
22. JONJIC N, PERI G, BERNASCONI S, SCIACCA FL, COLOTTA F, PELICCI P, LANFRANCONE L AND MANTOVANI A. (1992). Expression of adhesion molecules AND chemotactic cytokines in cultured human mesothefial cells. J, Exp. Med., 176, 1165-1174.
23. KERN PA, KNEDLER A AND ECKEL RH (1983). Isolation AND culture of microvascular endothelium from human adipose tissue. J, Clin. Invest., 71, 1822-1829.
24. LAEMMLI UK. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
25. O'HARA CJ, CORSON JM, PINKUS GS AND STAHEL RA. (1990). ME1 A monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma AND extrapulmonary malignancies. Am. J, Pathol., 136, 421-428.
26. OSBORN L, HESSION C, TIZARD R, VASSALLO C, LUHOWSKYJ S, CHI-ROSSO G AND LOBB R. (1989). Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell, 59, 1203-1211.
27. PATEL K, MOORE SE, DICKSON G, ROSSELL RJ, BEVERLY PC, KEMSHEAD JT AND WALSH FS. (1989). Neural cell adhesion molecule (NCAM) is the antigen recognized by monoclonal antibodies of similar specificity in small-cell lung carcinoma AND neuroblastoma. Int. J, Cancer, 44, 573-578.
28. RICE GE AND BEVILACQUA MP. (1989). An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science, 246, 1303-1306.
29. RICE GE, MUNRO JM, CORLESS C AND BEVILACQUA MP. (1991). Vascular AND nonvascular expression of INCAM-110. A target for mononuclear leukocyte adhesion in normal AND inflamed human tissues. Am. J, Pathol., 138, 385-393.
30. SAMBROOK J, FRJTSCH EF AND MANIATIS T. (1989). Molecular Cloning. A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press: Plainview, NY.
31. SANGER F, NICKLE S AND COULSON AR. (1977). DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74, 5463-5467.
32. SATO Y, MUKAI K, WATANABE S, GOTOH M AND SHIMOSATO Y. (1986). The AMeX method. A simplified technique of tissue processing AND paraffin embedding with improved preservation of antigens for immunostaining. Am. J, Pathol., 125, 431-435.
33. SEED B AND ARUFFO A. (1987). Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc. Natl Acad. Sci. USA, 84, 3365-3369.
34. SHEIBANI K, ESTEBAN JM, BAILEY A BATTIFORA H AND WEISS LM. (1992). Immunopathologic AND molecular studies as an aid to the diagnosis of malignant mesothelioma. Hum. Pathol., 23, 107-116.
35. SIMMONS PJ, MASINOVSKY B, LOGENECKER BM, BE REN SON R, TOROK-STORB B AND GALLATIN WM. (1992). Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood, 80, 388-395.
36. SOULE HD, VAZQUEZ J, LONG A, ALBERT S AND BRENNAN M. (1973). A human cell line from a pleural effusion derived from a breast carcinoma. J, Natl Cancer Inst., 51, 1409-1416.
37. STAHEL RA O'HARA CJ, WAIBEL R AND MARTIN A. (1988). Monoclonal antibodies against mesothelial membrane antigen discriminate between malignant mesothelioma AND lung adenocarcinoma. Int. J, Cancer, 41, 218-223.
38. TAGUCHI T, JHANWAR SC, SIEGFRIED JM, KELLER SM AND TESTA JR. (1993). Recurrent deletions of specific chromosomal sites in lp, 3p, 6q and 9p in human malignant mesothelioma. Cancer Res., 53, 4349-4355.
39. TAKAHASHI K, SAWASAKI Y, GOTO T, HATA J AND MUKAI K, Cobblestone monolayer cells from human omental adipose tissue are possibly mesothelial not endothelial. In vitro Cell Dev. Biol., 25, 109-111.
40. TAKAHASHI K, SAWASAKI Y, HATA J, MUKAI K AND TOTO T, Spontaneous transformation AND immortalization of human endothelial cells. In vitro Cell Dev. Biol., 25, 265-274.
41. TARENTINO AL, QUINONES G, TRUMBLE A, CHANGCHIEN L-M, DUCEMAN B, MALEY F AND PLUMMER TH. (1990). Molecular cloning AND amino acid sequence of peptide-AS-V-acetyl-P-D-glucosaminyl asparagine amidase from Flavobacterium meningosepticum. J, Biol. Chem., 265, 6961-6966.
42. WARHOL MJ, HICKEY WF AND CORSON JM. (1982). Malignant mesothelioma: ultrastructural distinction from adenocarcinoma. Am. J, Surg. Pathol., 6, 307-314.
43. YAMADA T, HIROHASHI S, SHIMOSATO Y, KODAMA T, HAYASHI S, OGURA T, GAMOU S AND SHIMIZU N. (1985). Giant cell carcinomas of the lung producing colony-stimulating factor in vitro AND in vivo. Jpn J, Cancer Res., 76, 967-976.
44. YAMADA T, HIROHASHI S, SHIMOSATO Y, WATANABE M, KAMIO S, KUNII T AND HAYATA Y. (1987). Monoclonal antibody raised by sera of a thymic mice bearing human lung cancer xenografts. Oncology, 44, 186-191.